More Contracts for Accenture - Analyst Blog
20 10월 2012 - 3:23AM
Zacks
Accenture Plc. (ACN) recently won a three-year
deal from Italian Medicines Agency (AIFA) for the development,
building and maintenance of an integrated Medicine Evaluation
System.
According to the contract, AIFA will be using Accenture’s
consulting and IT services, which is going to support AIFA’s
administration and medical technology processes.
Accenture’s implementation of certain technical solutions will
also help in strengthening AIFA’s relationship with end users.
Separately, Accenture is helping the insurance company AXA in
streamlining the financial processes in AXA’s European
operations.
This is basically under a multiyear deal, which was initiated in
2009. According to the deal, Accenture is helping AXA develop a
SAP-based technology platform. This will primarily take care of the
centralized finance and accounting (F&A) processes, which
includes payables management, accounts receivable, month-end close
and balance sheet reconciliations. The regions covered under this
program include France, Italy, Ireland, Portugal, Spain and the
U.K.
This should have a positive impact on Accenture in the near to
mid term and also generate new business opportunities for the
company. Other technology companies, such as Hewlett
Packard Company (HPQ) and Dell Inc.
(DELL) have also realized the increasing potential of the
consulting segment and are coming out with their own solutions to
tap the opportunity.
This apart, Accenture is also witnessing incremental growth from
technological changes such as SaaS/cloud, mobility, analytics and
digitization. Particularly, SaaS and cloud computing are other
areas for the company’s growth.
Accenture’s comprehensive service offerings have made it a key
IT service provider. A large product and service base has also led
the company to the top spot in the market. Moreover, government
orders continue to flow for the company.
We are encouraged by the steady flow of new businesses and
believe that the trend will continue. However, increasing
competition from IBM Corp. (IBM) and a cautious
spending environment may temper its growth prospects.
The company has a Zacks #2 Rank, implying a short-term Buy
rating.
ACCENTURE PLC (ACN): Free Stock Analysis Report
DELL INC (DELL): Free Stock Analysis Report
HEWLETT PACKARD (HPQ): Free Stock Analysis Report
INTL BUS MACH (IBM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Dell (NASDAQ:DELL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Dell (NASDAQ:DELL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024